In the process of developing a new drug, pharmaceutical companies perform clinical trials to test the drug. The collection and processing of clinical trials’ data accounts for 40% of the total cost of developing a new drug. This is no small amount, given that the average cost of drug development is $800 million. To capture data from clinical trials more effectively and efficiently. Big Pharma decided to convert to an online system.
The problem is that trial clinicians and vendors had been using a paper-based system since the company’s founding. The research and development teams feared that going to the standardized and automated format required by the online format would significantly hinder their creative processes. They feared that the online system would significantly stifle their flexibility to explore new ways to provide pharmaceutical- based medical care.

Required

a. Identify as many system analysis and design problems as you can in the case.

b. What can the company do to allay the clinician’s fear of the new system?